Blog
Enovis (ENOV) Q3 Earnings and Revenues Beat Estimates
Enovis (ENOV) came out with quarterly earnings of $0.75 per share, beating the Zacks Consensus Estimate of $0.67 per share. This compares to earnings of $0.73 per share a year ago. These figures are
Celsius Holdings Inc. (CELH) Q3 Earnings and Revenues Top Estimates
Celsius Holdings Inc. (CELH) came out with quarterly earnings of $0.42 per share, beating the Zacks Consensus Estimate of $0.28 per share. This compares to break-even earnings per share a year ago
ACI Worldwide (ACIW) Q3 Earnings and Revenues Beat Estimates
ACI Worldwide (ACIW) came out with quarterly earnings of $1.09 per share, beating the Zacks Consensus Estimate of $0.99 per share. This compares to earnings of $0.97 per share a year ago. These
Ashland Q4 Earnings Miss Estimates on Portfolio Actions, Revenues Down
Ashland Global Holdings Inc. ASH recorded a profit of $32 million or 71 cents per share for the fourth-quarter fiscal 2025 (ended Sept. 30, 2025) compared with a profit of $16 million or 33 cents in
3 Mutual Funds to Capitalize on the Financial Sector Upswing
The financial sector has been one of Wall Street’s steadier stories in 2025, with the Financial Select Sector SPDR (XLF) up roughly 10% year to date as of Nov. 5. That gain reflects a mix of
Walker & Dunlop (WD) Surpasses Q3 Earnings and Revenue Estimates
Walker & Dunlop (WD) came out with quarterly earnings of $1.22 per share, beating the Zacks Consensus Estimate of $1.21 per share. This compares to earnings of $1.19 per share a year ago. These
Oscar Health, Inc. (OSCR) Reports Q3 Loss, Lags Revenue Estimates
Oscar Health, Inc. (OSCR) came out with a quarterly loss of $0.53 per share versus the Zacks Consensus Estimate of a loss of $0.55. This compares to a loss of $0.22 per share a year ago. These
Esperion Therapeutics (ESPR) Reports Q3 Loss, Tops Revenue Estimates
Esperion Therapeutics (ESPR) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to a loss of $0.15 per share a year ago. These
Air Products and Chemicals (APD) Misses Q4 Earnings and Revenue Estimates
Air Products and Chemicals (APD) came out with quarterly earnings of $3.39 per share, missing the Zacks Consensus Estimate of $3.41 per share. This compares to earnings of $3.56 per share a year
A.P. Moller-Maersk (AMKBY) Misses Q3 Earnings and Revenue Estimates
A.P. Moller-Maersk (AMKBY) came out with quarterly earnings of $0.31 per share, missing the Zacks Consensus Estimate of $0.51 per share. This compares to earnings of $0.99 per share a year ago
Is American Funds AMCAP A (AMCPX) a Strong Mutual Fund Pick Right Now?
There are plenty of choices in the Large Cap Growth category, but where should you start your research? Well, one fund that might be worth investigating is American Funds AMCAP A (AMCPX). AMCPX
Is T. Rowe Price Mid-Cap Growth Adviser (PAMCX) a Strong Mutual Fund Pick Right Now?
If you've been stuck searching for Mid Cap Growth funds, consider T. Rowe Price Mid-Cap Growth Adviser (PAMCX) as a possibility. PAMCX carries a Zacks Mutual Fund Rank of 2 (Buy), which is based on
Is Fidelity Advisor Equity Growth M (FAEGX) a Strong Mutual Fund Pick Right Now?
Looking for a Large Cap Growth fund? You may want to consider Fidelity Advisor Equity Growth M (FAEGX) as a possible option. FAEGX has a Zacks Mutual Fund Rank of 3 (Hold), which is based on various
Is BlackRock Advantage Small Cap Core A (BDSAX) a Strong Mutual Fund Pick Right Now?
Having trouble finding a Small Cap Blend fund? BlackRock Advantage Small Cap Core A (BDSAX) is a potential starting point. BDSAX holds a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based on
Is Victory Pioneer Core Equity A (PIOTX) a Strong Mutual Fund Pick Right Now?
If you've been stuck searching for All Cap Value funds, you might want to consider passing on by Victory Pioneer Core Equity A (PIOTX) as a possibility. PIOTX possesses a Zacks Mutual Fund Rank of 5
The Zacks Analyst Blog Highlights Tesla, BlackRock and Welltower
For Immediate Release
Chicago, IL – November 6, 2025 – Zacks.com announces the list of stocks and ETFs featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest
The Zacks Analyst Blog Highlights Backblaze, Datadog, JFrog, Affirm and Block
For Immediate Release
Chicago, IL – November 6, 2025 – Zacks.com announces the list of stocks and ETFs featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest
The Zacks Analyst Blog Highlights NVIDIA, Alphabet, Amazon.com and Palantir
For Immediate Release
Chicago, IL – November 6, 2025 – Zacks.com announces the list of stocks and ETFs featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest
The Zacks Analyst Blog Highlights Amazon, Alphabet, Oracle and Microsoft
For Immediate Release
Chicago, IL – November 6, 2025 – Zacks.com announces the list of stocks and ETFs featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest
Should You Invest in the State Street SPDR S&P Retail ETF (XRT)?
Looking for broad exposure to the Consumer Discretionary - Retail segment of the equity market? You should consider the State Street SPDR S&P Retail ETF (XRT), a passively managed exchange traded
Is State Street SPDR S&P Bank ETF (KBE) a Strong ETF Right Now?
Launched on 11/08/2005, the State Street SPDR S&P Bank ETF (KBE) is a smart beta exchange traded fund offering broad exposure to the Financials ETFs category of the market.
What Are Smart Beta
The Zacks Analyst Blog Highlights MasterCraft, Melco Resorts & Entertainment Ltd. and Planet Fitness
For Immediate Release
Chicago, IL – November 6, 2025 – Zacks.com announces the list of stocks and ETFs featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest
New Strong Buy Stocks for November 6th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Medpace Holdings, Inc. MEDP: This clinical research-based drug and medical devices company has seen the Zacks Consensus
New Strong Sell Stocks for Nov. 6
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:
Acadia Healthcare Company, Inc. ACHC is a provider of behavioral healthcare services. The Zacks Consensus Estimate for its
Best Growth Stocks to Buy for Nov. 6
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, Nov. 6:
Fox Corporation FOXA: This news, sports, and entertainment company carries a Zacks


